Clinical trials
Peptides clinical trials
Below are recruiting peptides clinical trials, each written for real people, not researchers. We’re tracking 144 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06783660Recruiting
Graft material for preserving tooth socket after extraction
This trial tests a new collagen-based graft material used to preserve the bone socket right after a tooth is removed. The goal is to keep the bone healthy so that a dental implant can be placed later.
Korea, SeoulAges 19–75 - NCT02358187RecruitingPhase 2
Vaccine for children and teens with low-grade brain tumors
This trial tests a peptide vaccine plus a medication called poly-ICLC for people with certain low-grade gliomas that cannot be fully removed. The goal is to help the immune system recognize and attack the tumor.
Pittsburgh, PennsylvaniaAges 1–21 - NCT06654219Recruiting
Clear liquids before endoscopy for patients on GLP-1 meds
This study tests whether drinking only clear liquids before an upper endoscopy can reduce leftover stomach contents in people taking GLP-1 medications (like Ozempic or Mounjaro). It may help make the procedure safer.
Houston, TexasAges 18 years+ - NCT07529249Recruiting
Oral Collagen Peptides for Skin Barrier Function in Women
This study tests whether taking collagen peptides by mouth can improve dry skin and strengthen the skin barrier in women ages 45–70. Researchers will measure changes in skin moisture and texture over time.
NiceAges 45–70 - NCT07586930Recruiting
Testing a Supplement for Intestinal Health
This study tests whether a daily supplement can help improve gut health and reduce digestive symptoms like bloating, cramping, or irregular bowel habits. You'll undergo simple urine tests to measure how well your intestines are working.
Cork, IrelandAges 18–65 - NCT06016855RecruitingPhase 4
Surgery before radiation therapy for neuroendocrine tumors
This trial tests if removing as much tumor as possible through surgery before a targeted radiation therapy (PRRT) can help people with well-differentiated neuroendocrine tumors that have spread to the liver. The goal is to see if this approach works better than radiation therapy alone.
Nashville, TennesseeAges 18 years+ - NCT07317154RecruitingPhase 1
Dendritic cell vaccine for HPV type 6 recurrent respiratory papillomatosis
This Phase 1 trial is testing a vaccine made from your own immune cells (dendritic cells) that may help your body fight the virus causing recurrent papillomas in your voice box. It is for people whose papillomas are caused by HPV type 6, who have had at least one recurrence in the past year.
Scottsdale, ArizonaAges 18 years+ - NCT07229014Recruiting
Collagen supplement for quality of life and appetite
This trial tests whether a daily collagen supplement can improve quality of life, appetite, and blood sugar control in overweight adults who feel low energy or have trouble sleeping. You will take the supplement, use a continuous glucose monitor, and complete online surveys.
London, LondonAges 18–65 - NCT07123545RecruitingPhase 1/Phase 2
Personalized T-cell therapy for advanced liver cancer
This trial tests a personalized treatment using your own immune cells (T-cells) trained to attack specific markers on your liver cancer. It is for people with advanced liver cancer that has worsened after at least two prior treatments and who have tumor tissue available for genetic testing.
Hangzhou, ZhejiangAges 18–75 - NCT07319130Enrolling by invitation
Testing a new PET scan for Nectin-4-positive tumors
This trial tests a new imaging injection (a radioactive tracer called 68Ga) that sticks to a protein called Nectin-4, which is often found on cancer cells. The goal is to see if this scan can better find tumors in people with certain solid cancers, such as bladder, breast, or lung cancer.
Suzhou, JiangsuAges 18 years+ - NCT06789198RecruitingPhase 1
Peptide Vaccine for Fibrolamellar Cancer and Related Tumors
This trial tests a vaccine designed to target cancer cells with a specific genetic change (DNAJB1-PRKACA). It is for people whose fibrolamellar liver cancer or other tumors with this change are in complete remission after prior treatment, to help prevent the cancer from coming back.
TübingenAges 12 years+ - NCT07231705Recruiting
Plant-based formula for growth and tolerance in toddlers
This study tests how well toddlers (12-17 months old) tolerate and grow on a plant-based formula. It compares this new formula to standard ones for children who get most of their calories from formula.
Columbus, OhioAges 1 year–1.4 years - NCT07614698Recruiting
Testing a peptide cream for healthy skin recovery
This study tests whether a peptide-based cream (a product containing small protein fragments) helps healthy skin recover better. Researchers will apply it to your forearm and measure how your skin responds over time.
SplitAges 18–50 - NCT07437586RecruitingPhase 2
Copper-peptide gel for healing acute skin wounds
This trial tests a copper-peptide gel applied to a small, fresh wound to see if it helps healing. It is meant for healthy adults aged 18 to 55 who are not smokers and have no skin problems or conditions that slow healing.
Shenzhen, GuangdongAges 18–55 - NCT07289932Enrolling by invitation
Peptide vs fluoride varnish for white spots on teeth
This study compares a new peptide treatment to a standard fluoride varnish for reversing small white spots on teeth (early cavities) in teens and young adults. You’ll receive one treatment on one side of your mouth and the other treatment on the other side, and we’ll see which works better.
CairoAges 15–25 - NCT06689761Enrolling by invitation
Collagen peptides and exercise: muscle strength study
This trial tests whether taking collagen peptides before exercise can improve how your muscles adapt to strength training. It could help you build muscle more effectively.
Vienna, State of ViennaAges 18–40 - NCT06314087RecruitingPhase 2
Personalized cancer vaccine with radiation therapy
This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.
Shenzhen, GuangdongAges 18–80 - NCT04365179RecruitingPhase 1
NEROFE for advanced MDS or AML after other treatments
This early-phase trial tests NEROFE, a hormone-peptide medicine, in adults with advanced myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back or did not respond. It aims to see if NEROFE is safe and can help patients whose disease is unlikely to benefit from standard remaining options.
Miami, FloridaAges 18 years+ - NCT07740967Recruiting
Collagen and omega supplements for middle-aged women
This study tests whether daily collagen and omega-3 supplements can improve health in healthy middle-aged women. You would take the supplements for a period and have your health measured.
LoughboroughAges 35–65 - NCT05951816RecruitingPhase 1
Imaging study for amyloidosis in heart and body
This study tests a new imaging agent (99mTc-p5+14) that helps doctors see amyloid deposits in the body, especially in the heart. It is for healthy volunteers and people with AL or ATTR amyloidosis that has affected the heart.
Knoxville, TennesseeAges 18 years+ - NCT07575399RecruitingPhase 3
Switching to a New Weight-Loss Medication From Current GLP-1
This trial tests whether switching from your current GLP-1 medication (like Ozempic or Wegovy) to a new drug called maridebart cafraglutide works as well or better for weight management. You must have already lost at least 10% of your body weight on your current GLP-1 and be doing well with it.
Pelham, AlabamaAges 18–99 - NCT06529822RecruitingPhase 1
Personalized cancer vaccine for solid tumors with MRD
This trial tests a personalized cancer vaccine for people with certain cancers (bladder, stomach/esophagus, melanoma, or lung) who have no visible cancer after surgery but still have tiny bits of cancer DNA in their blood (called MRD). The vaccine is designed to train your immune system to attack any remaining cancer cells.
Orlando, FloridaAges 18 years+ - NCT04216342RecruitingPhase 1
Testing a new breathing-drug ingredient in healthy adults
This early study (Phase 1) tests how safe and tolerable Fx-5A is, and how the body processes it, in healthy volunteers. It’s mainly looking to understand side effects and drug levels rather than treating a disease.
Bethesda, MarylandAges 18–99 - NCT03606967RecruitingPhase 2
Individualized vaccine added to standard treatment for metastatic triple-negative breast cancer
This Phase 2 trial tests whether adding a personalized cancer vaccine to durvalumab (an immunotherapy), tremelimumab (another immunotherapy), and chemotherapy can improve outcomes for people with metastatic triple-negative breast cancer. It may help your immune system recognize your specific tumor features.
Orange, CaliforniaAges 18 years+
Hear when a new Peptides trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for peptides?
- Yes. Clin2 currently lists 144 recruiting peptides studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a peptides trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a peptides trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.